One-year mortality and readmission risks following hospitalization for acute exacerbation of chronic obstructive pulmonary disease based on the types of acute respiratory failure: An observational study
Open Access
- 28 June 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (26) , e38644
Abstract
Few studies have examined the risk factors associated with the type of acute respiratory failure (ARF) in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD). This study evaluated the clinical characteristics and prognosis of patients hospitalized for acute exacerbation of COPD based on the type of ARF. The medical charts of hospitalized patients with acute exacerbation of COPD between 2016 and 2021 were retrospectively reviewed. We classified ARF into 2 types: type 1 ARF with PaO 2 < 60 mm Hg in room air or a ratio of arterial partial pressure to fractional inspired oxygen < 300, and type 2 ARF with PaCO 2 > 45 mm Hg and arterial pH < 7.35. A total of 435 patients were enrolled in study, including 170 participants without ARF, 165 with type 1 ARF, and 100 with type 2 ARF. Compared with the non-ARF group, the frequency of high-flow nasal cannula, noninvasive ventilation, intensive care unit admissions, and in-hospital deaths was higher in the ARF group compared with the non-ARF group. The ARF group had higher 1-year mortality group (hazard ratio [HR], 2.809; 95% confidence interval [CI], 1.099–7.180; P = .031) and readmission within 1-year rates (HR, 1.561; 95% CI, 1.061–2.295; P = .024) than the non-ARF group. The type 1 ARF group had a higher risk of 1-year mortality (HR, 3.022; 95% CI, 1.041–8.774; P = .042) and hospital readmission within 1-year (HR, 2.053; 95% CI, 1.230–3.428; P = .006) compared with the non-ARF group. There was no difference in mortality and readmission rates between the type 1 and type 2 ARF groups. In conclusion, patients with type 1 ARF rather than type 2 ARF had higher mortality and readmission rates than those without ARF. The prognoses of patients with type 1 and type 2 ARF were similar.Keywords
This publication has 18 references indexed in Scilit:
- Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive SummaryAmerican Journal of Respiratory and Critical Care Medicine, 2023
- Impact of pulmonary hypertension in patients with acute exacerbation of chronic obstructive pulmonary disease and its effect on healthcare utilizationPulmonary Circulation, 2021
- Improving lung health in low-income and middle-income countries: from challenges to solutionsThe Lancet, 2021
- Long term survival after admission for COPD exacerbation: A comparison with the general populationRespiratory Medicine, 2018
- Is elevated troponin associated with in-hospital mortality in emergency department patients admitted with chronic obstructive pulmonary disease?European Journal of Emergency Medicine, 2013
- Predictors of Adverse Outcome in Patients Hospitalised for Exacerbation of Chronic Obstructive Pulmonary DiseaseRespiration, 2012
- Factors affecting survival of hospitalised patients with COPDEuropean Respiratory Journal, 2005
- Respiratory failure in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2003
- Non-invasive ventilation in acute respiratory failureThorax, 2002
- Reversible hypercapnia in chronic obstructive pulmonary disease: A distinct pattern of respiratory failure with a favorable prognosisThe American Journal of Medicine, 1997